UIC
BLFS icon

Uniplan Investment Counsel’s BioLife Solutions BLFS Stock Holding History

Uniplan Investment Counsel’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.49M Sell
182,837
-11,780
-6% -$260K 0.36% 72
2025
Q4 		$4.71M Sell
194,617
-146
-0.1% -$3.82K 0.47% 62
2025
Q3 		$4.97M Sell
194,763
-31,905
-14% -$757K 0.49% 60
2025
Q2 		$4.88M Sell
226,668
-20,710
-8% -$467K 0.49% 51
2025
Q1 		$5.65M Buy
247,378
+1,861
+0.8% +$49K 0.55% 49
2024
Q4 		$6.37M Sell
245,517
-3,132
-1% -$77.9K 0.59% 45
2024
Q3 		$6.23M Sell
248,649
-4,095
-2% -$96.7K 0.54% 45
2024
Q2 		$5.42M Sell
252,744
-1,116
-0.4% -$21.7K 0.49% 50
2024
Q1 		$4.71M Buy
253,860
+6,493
+3% +$114K 0.37% 60
2023
Q4 		$4.13M Sell
247,367
-13,712
-5% -$175K 0.31% 67
2023
Q3 		$3.67M Buy
261,079
+775
+0.3% +$12.2K 0.28% 74
2023
Q2 		$5.75M Sell
260,304
-1,202
-0.5% -$25.3K 0.42% 60
2023
Q1 		$5.69M Buy
261,506
+37,289
+17% +$839K 0.4% 58
2022
Q4 		$4.08M Buy
224,217
+89,669
+67% +$1.85M 0.29% 76
2022
Q3 		$3.06M Sell
134,548
-388
-0.3% -$8.3K 0.23% 85
2022
Q2 		$1.86M Buy
+134,936
New +$1.98M 0.13% 111

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Uniplan Investment Counsel's BLFS Position: Q1 2026 in Review

Uniplan Investment Counsel reduced its BioLife Solutions (BLFS) stake by 6.1% in Q1 2026, selling an estimated $260K and leaving 182,837 shares worth $3.49M. The position accounts for 0.36% of the portfolio, ranked #72.

Uniplan Investment Counsel first reported a position in BLFS in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.37M in Q4 2024. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Uniplan Investment Counsel held 182,837 shares of BioLife Solutions worth $3.49M as of Q1 2026.
  • Uniplan Investment Counsel sold 11,780 BioLife Solutions shares in Q1 2026, an estimated $260K.
  • BioLife Solutions made up 0.36% of Uniplan Investment Counsel's portfolio in Q1 2026, its #72 holding.
  • Uniplan Investment Counsel first reported a position in BioLife Solutions in Q2 2022 and has held it in 16 quarters since.
  • Uniplan Investment Counsel's BioLife Solutions position peaked at $6.37M in Q4 2024.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Uniplan Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.